MatchaDB

2023학술 논문무료 열람

Editorial: Women in gastrointestinal cancers, volume II: 2022

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee

Frontiers in Oncology

출판사에서 읽기→무료 전문→PubMed

초록

Women in Gastrointestinal Cancer Vol II: 2022 EDITORIAL This editorial presents the inaugural Frontiers in Oncology (FIO) 'Women in Gastrointestinal Cancer Vol II: 2022" series of article collections. The research topic collection highlights the diversity of research performed across the entire breadth of oncology research by women scientists pursuing STEM careers. Nine (9) research articles, from 14 submitted to FIO within this section, published under this research topic by 92 authors, aimed to present advances in theory, experiment, and methodology, with applications to compelling problems related to gastric cancers: gastrointestinal (GI) cancer: Hepato-Pancreatic Biliary (HPB) cancers. 1/9 is a brief research report article titled "the BET inhibitor JQ1 potentiates the anticlonogenic effect of radiation in pancreatic cancer cells". 1/9 is a case report article titled "a female with synchronous multiple primary malignant tumors in the esophagogastric junction, duodenum, and pancreas: Case report and review of the literature". Methodology Clinical trial article 1/9 under the title "implementing pharmacogenetic testing in gastrointestinal cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 screening to guide chemotherapy dosing". Four out of the nine (4/9) published articles are original research articles exploring the tumor-immune interactions in the tumor microenvironment (TME) and identifying new prognostic and/or therapeutic biomarkers to assist in novel decoding mechanism(s) of tumor immunotherapy as well as being confined with personalized treatment based on geno/pheno-typic evaluations. These four articles are, first "Evaluation of Galanin Expression in Colorectal Cancer (CRC): An Immunohistochemical (IHC)…

초록이 줄여졌습니다. 출처에서 초록 전문 읽기.

초록 텍스트는 PubMed, OpenAlex 또는 Europe PMC에서 가져온 것이며 저자와 출판사에 귀속됩니다.

연구 유형

체계적 문헌고찰·메타분석

이전 연구를 체계적으로 검색하고 종합 분석한 것.

제목, 초록, 주제어에서 자동으로 지정됩니다.

주제

여기서는 말차가 주요 주제입니다(키워드에 명시).

키워드와 주제어

내 연구 폴더

이 연구 인용하기

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee. (2023). Editorial: Women in gastrointestinal cancers, volume II: 2022. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1192814

DOI: 10.3389/fonc.2023.1192814 · PubMed ID: 37265801

대사와 체중에 대해 더 보기

2018학술 논문무료 열람

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

시험관·세포 연구대사와 체중항산화 물질과 폴리페놀암75회 인용됨
2020학술 논문

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ 외 — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

동물 연구대사와 체중장과 마이크로바이옴시장·문화·지속 가능성74회 인용됨

라이브러리 전체 둘러보기→